Clinical Trial Detail

NCT ID NCT01270321
Title A Trial of Pasireotide and Everolimus in Adult Patients With Radioiodine-Refractory Differentiated and Medullary Thyroid Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors Emory University
Indications

thyroid cancer

Therapies

Pasireotide

Everolimus

Age Groups: adult

No variant requirements are available.